Feasibility and psychometrics of an ambulatory hot flash monitoring device

Feasibility and psychometrics of an ambulatory hot flash monitoring device
复制标题

DOI:
10.1097/00042192-199906030-00006
复制
发表时间:
1999-09-01
影响因子:
2.7
通讯作者:
Munn, R
Munn, R
中科院分区:
医学3区
文献类型:
--
作者:
Carpenter, JS;Andrykowski, MA;Munn, R

文献摘要

被引文献

相似文献

目的:为了评估一个轻量级的,自动化的,动态胸骨皮肤电导监测仪的可行性和心理测量特性,以测量乳腺癌幸存者(BCS)中潮热(HF)的频率,设计:共有19名绝经后BCS和5名绝经前健康对照妇女参加了24小时的正常日常活动,包括睡眠期间佩戴监测仪。使用主观(日记,事件标记)和客观(皮肤电导)methods.Results:问题与主观报告的高频被报告的BCS的35%。与佩戴监护仪相关的技术问题和不适最小。17名BCS和5名绝经前妇女(BCS组M = 13.4;范围,1-30)使用皮肤电导监测仪共记录了243例HF。皮肤电导监测在清醒的时间与30%的假阴性率。结论:监测是一种可行的方法,客观地评估在BCS的高频。数据支持继续使用胸骨皮肤电导作为HF频率的客观测量。这项技术应被证明是有用的,作为一个客观的措施,在未来的干预研究,旨在减轻症状,提高生活质量的BCS。(C)1999年,北美更年期协会。
Objective: To assess the feasibility and psychometric properties of a lightweight, automated, ambulatory sternal skin conductance monitor to measure frequency of hot flashes (HFs) among breast cancer survivors (BCSs),Design: A total of 19 postmenopausal BCSs and 5 premenopausal healthy comparison women participated by wearing the monitor for 24 h during their normal daily activities, including sleep. HFs were assessed using subjective (diaries, event markers) and objective (skin conductance) methods.Results: Problems with subjective reporting of HFs were reported by 35% of BCSs. Technological problems and discomfort related to wearing the monitor were minimal. A total of 243 HFs were recorded using the skin conductance monitor by 17 BCSs and 5 premenopausal women (BCS group M = 13.4; range, 1-30), Subjective reporting of HFs was associated with a 31-33% false-positive rate. Skin conductance monitoring during waking hours was associated with a 30% false-negative rate.Conclusions: The monitor is a feasible method for objectively assessing HFs in BCSs. Data support continued use of sternal skin conductance as an objective measure of HF frequency. This technology should prove useful as an objective measure of HFs in future intervention research aimed at alleviating the symptom and improving quality of Life among BCSs. (C) 1999, The North American Menopause Society.